Becton falls after co to merge biosciences and diagnostics unit with Waters

Waters

14/07/2025 11:53

** Shares of medical device maker Becton Dickinson BDX.N fall 2.3% to $172 premarket

** Co to combine its biosciences and diagnostic solutions business with Waters in a deal valued at about $17.5 billion

** Shares of Waters Corp WAT.N down 5% at $335 premarket

** The deal is structured as a Reverse Morris Trust, which allows a company to avoid a big tax bill by spinning off a unit that it wants to divest while simultaneously merging it with another company

     ** The transaction is expected to close around the end of the first quarter of 2026

** The combined company will continue to operate under the Waters name, and is expected to generate pro forma revenue of about $6.5 billion

** Up to last close, BDX down 22.4% and WAT down 4.9% YTD

 (Reporting by Sneha S K)

 ((Sneha.SK@thomsonreuters.com))